We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CSPC Pharmaceutical Group Limited | TG:CVG | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.013 | -2.06% | 0.6176 | 0.6026 | 0.6322 | 0.6324 | 0.6316 | 0.6324 | 4,500 | 22:50:08 |
Convergys Corp.'s (CVG) posted a narrower third-quarter loss on smaller write-downs, as well as new business signings and continuing solid margins in its customer-management business.
The provider of integrated billing, employee care and customer-care services also forecast fourth-quarter earnings, excluding items, of at least 30 cents a share on revenue of $650 million to $670 million. Analysts were expecting earnings of 26 cents a share on revenue of $667 million.
Business-services providers have been hurt by an overall pullback in corporate spending as the economy languishes.
Convergys said its third-quarter loss narrowed to $86 million, or 70 cents a share, from $140 million, or $1.15 a share. Excluding charges, including a year-ago $272.9 million charge related to human resources management contracts, earnings fell to 27 cents a share from 29 cents a share.
Revenue rose 13% to $765.4 million, including $106 million in deferred revenue from an HR-unit contract.
Analysts polled by Thomson Reuters were expecting earnings, excluding items, of 23 cents a share on revenue of $653 million.
Customer-management profit, excluding items, rose 61% on a 2% revenue rise and sharply higher margins. The much-smaller information-management segment, which offers bill processing services and software to telecommunications companies, had a 47% earnings drop as revenue fell 26%.
Convergys shares closed at $10.66 and didn't trade premarket. The stock has surged 66% this year.
-By Mike Barris, Dow Jones Newswires; 212-416-2330; mike.barris@dowjones.com
1 Year CSPC Pharmaceutical Chart |
1 Month CSPC Pharmaceutical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions